Join leading experts from Bayer, Health Canada, Arthritis Society, and Knight Therapeutics as they dive deep into the challenges of bringing innovative treatments to Canadian patients. Key highlights include: insights from regulatory, industry, and patient perspectives, challenges in Canada’s drug approval process, innovative approaches to streamline market access and more.

In this panel discussion, industry leaders explore:

• Current bottlenecks in drug approval and reimbursement
• Strategies to accelerate patient access to new treatments
• Collaborative approaches between government, industry & patient groups
• Future solutions for a more efficient healthcare system

Featuring:

• Jody Engel (Knight Therapeutics)
• Brendon Levac (Bayer Healthcare)
• Dr. Alysha Croker (Health Canada)
• Kelly Gorman (Arthritis Society Canada)